Request for Covid-19 Impact Assessment of this Report
The global Novel Drug Delivery Systems market will reach Volume Million USD in 2017 with CAGR xx% 2019-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Amgen
Teva
UCB?(Union Chimique Belge)
Roche
Celgene
Sanofi
Merck
Johnson & Johnson
Takeda
Gilead Sciences
Pfizer
Dr Reddy
Samyang Biopharmaceuticals
TOLMAR
Astellas
AMAG?Pharmaceuticals
AstraZeneca
AbbVie
Bausch?Lomb
TWi Pharmaceuticals
Novartis
Aspen
Shire
Breckenridge Pharmaceuticals
Galen
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospitals & Clinic
Cancer Treatment Centers
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Liposomes
1.2.1.2 PEGylated Proteins & Polypeptides
1.2.1.3 Polymer Nanoparticle
1.2.1.4 Protein–drug Conjugates
1.2.1.5 Others
1.2.2 by Application
1.2.2.1 Hospitals & Clinic
1.2.2.2 Cancer Treatment Centers
1.2.2.3 Others
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Liposomes Market, 2013-2018
4.1.2 PEGylated Proteins & Polypeptides Market, 2013-2018
4.1.3 Polymer Nanoparticle Market, 2013-2018
4.1.4 Protein–drug Conjugates Market, 2013-2018
4.1.5 Others Market, 2013-2018
4.2 Market Forecast
4.2.1 Liposomes Market Forecast, 2019-2023
4.2.2 PEGylated Proteins & Polypeptides Market Forecast, 2019-2023
4.2.3 Polymer Nanoparticle Market Forecast, 2019-2023
4.2.4 Protein–drug Conjugates Market Forecast, 2019-2023
4.2.5 Others Market Forecast, 2019-2023
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospitals & Clinic Market, 2013-2018
5.1.2 Cancer Treatment Centers Market, 2013-2018
5.1.3 Others Market, 2013-2018
5.2 Market Forecast
5.2.1 Hospitals & Clinic Market Forecast, 2019-2023
5.2.2 Cancer Treatment Centers Market Forecast, 2019-2023
5.2.3 Others Market Forecast, 2019-2023
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Amgen
8.2 Teva
8.3 UCB?(Union Chimique Belge)
8.4 Roche
8.5 Celgene
8.6 Sanofi
8.7 Merck
8.8 Johnson & Johnson
8.9 Takeda
8.10 Gilead Sciences
8.11 Pfizer
8.12 Dr Reddy
8.13 Samyang Biopharmaceuticals
8.14 TOLMAR
8.15 Astellas
8.16 AMAG?Pharmaceuticals
8.17 AstraZeneca
8.18 AbbVie
8.19 Bausch?Lomb
8.20 TWi Pharmaceuticals
8.21 Novartis
8.22 Aspen
8.23 Shire
8.24 Breckenridge Pharmaceuticals
8.25 Galen
9 Conclusion
Table Product Specifications of Novel Drug Delivery Systems
Table Products Segment of Novel Drug Delivery Systems
Table Liposomes Overview
Table PEGylated Proteins & Polypeptides Overview
Table Polymer Nanoparticle Overview
Table Protein–drug Conjugates Overview
Table Others Overview
Table Global Novel Drug Delivery Systems Market by Type, 2011-2022 (USD Million)
Table Application Segment of Novel Drug Delivery Systems
Table Hospitals & Clinic Overview
Table Cancer Treatment Centers Overview
Table Others Overview
Table Global Novel Drug Delivery Systems Market by Application, 2011-2022 (USD Million)
Table Global Novel Drug Delivery Systems Market by Region, 2011-2022 (USD Million)
Table Cost of Novel Drug Delivery Systems
Table Market Dynamics
Table Policy of Novel Drug Delivery Systems
Table GDP of Major Countries
Table Liposomes CAGR by Revenue and Volume, 2012-2018
Table PEGylated Proteins & Polypeptides CAGR by Revenue and Volume, 2012-2018
Table Polymer Nanoparticle CAGR by Revenue and Volume, 2012-2018
Table Protein–drug Conjugates CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Liposomes CAGR by Revenue and Volume, 2012-2022
Table PEGylated Proteins & Polypeptides CAGR by Revenue and Volume, 2012-2022
Table Polymer Nanoparticle CAGR by Revenue and Volume, 2012-2022
Table Protein–drug Conjugates CAGR by Revenue and Volume, 2012-2022
Table Others CAGR by Revenue and Volume, 2012-2022
Table Hospitals & Clinic CAGR by Revenue and Volume, 2012-2018
Table Cancer Treatment Centers CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Global Novel Drug Delivery Systems Market by Vendors, 2012-2018 (USD Million)
Table Global Novel Drug Delivery Systems Market by Vendors, 2012-2018 (in Volume)
Table Global Novel Drug Delivery Systems Market Share by Vendors, 2012-2018 (USD Million)
Table Global Novel Drug Delivery Systems Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Amgen Profile List
Table Microecological Modulator Operating Data of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Profile List
Table Microecological Modulator Operating Data of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table UCB?(Union Chimique Belge) Profile List
Table Microecological Modulator Operating Data of UCB?(Union Chimique Belge) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Profile List
Table Microecological Modulator Operating Data of Celgene (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Profile List
Table Microecological Modulator Operating Data of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Profile List
Table Microecological Modulator Operating Data of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Profile List
Table Microecological Modulator Operating Data of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Sciences Profile List
Table Microecological Modulator Operating Data of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr Reddy Profile List
Table Microecological Modulator Operating Data of Dr Reddy (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Samyang Biopharmaceuticals Profile List
Table Microecological Modulator Operating Data of Samyang Biopharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table TOLMAR Profile List
Table Microecological Modulator Operating Data of TOLMAR (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Profile List
Table Microecological Modulator Operating Data of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AMAG?Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of AMAG?Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Profile List
Table Microecological Modulator Operating Data of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Profile List
Table Microecological Modulator Operating Data of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bausch?Lomb Profile List
Table Microecological Modulator Operating Data of Bausch?Lomb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table TWi Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of TWi Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aspen Profile List
Table Microecological Modulator Operating Data of Aspen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shire Profile List
Table Microecological Modulator Operating Data of Shire (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Breckenridge Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Breckenridge Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Galen Profile List
Table Microecological Modulator Operating Data of Galen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...